Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Update

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a large decline in short interest in the month of August. As of August 31st, there was short interest totaling 700 shares, a decline of 22.2% from the August 15th total of 900 shares. Based on an average daily trading volume, of 7,500 shares, the short-interest ratio is presently 0.1 days. Based on an average daily trading volume, of 7,500 shares, the short-interest ratio is presently 0.1 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Up 0.2%

Shares of HROWM stock opened at $26.11 on Friday. The company has a 50-day simple moving average of $26.24 and a 200 day simple moving average of $26.35. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52 week low of $24.90 and a 52 week high of $27.70.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, July 31st. Shareholders of record on Tuesday, July 15th were issued a $0.7422 dividend. The ex-dividend date of this dividend was Tuesday, July 15th. This represents a $2.97 dividend on an annualized basis and a yield of 11.4%. This is an increase from Harrow Health, Inc. 11.875% Senior Notes due 2027’s previous quarterly dividend of $0.74.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.